The 1 analysts offering 12-month price forecasts for Phio Pharmaceuticals Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +68.78% increase from the last price of 2.37.
The current consensus among 1 polled investment analysts is to Buy stock in Phio Pharmaceuticals Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.42
Reporting Date Mar 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.